Satake, H., Tsuji, A., Nakamura, M., Ogawa, M., Kotake, T., Hatachi, Y., . . . Fujii, M. (2018). Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: The JACCRO CC-14 study. Int J Clin Oncol.
Citação norma ChicagoSatake, Hironaga, et al. "Phase I Study of Primary Treatment With 5-FU, Oxaliplatin, Irinotecan, Levofolinate, and Panitumumab Combination Chemotherapy in Patients With Advanced/recurrent Colorectal Cancer Involving the Wild-type RAS Gene: The JACCRO CC-14 Study." Int J Clin Oncol 2018.
ציטוט MLASatake, Hironaga, et al. "Phase I Study of Primary Treatment With 5-FU, Oxaliplatin, Irinotecan, Levofolinate, and Panitumumab Combination Chemotherapy in Patients With Advanced/recurrent Colorectal Cancer Involving the Wild-type RAS Gene: The JACCRO CC-14 Study." Int J Clin Oncol 2018.